Postremission therapy in older adults with acute myeloid leukemia: an opportunity for new drug development. | Leukemia;16(4): 745-7, 2002 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Postremission therapy in older adults with acute myeloid leukemia: an opportunity for new drug development.

Schiffer, C A.

Affiliation

Schiffer CA; Karmanos Cancer Institute and the Division of Hematology/Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA.

Leukemia ; 16(4): 745-7, 2002 Apr.

Article in En | MEDLINE | ID: mdl-11960360

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Leukemia, Myeloid Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2002 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Leukemia, Myeloid Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2002 Document type: Article Affiliation country: Country of publication: